Home > News > pSivida Expands Market for Lead Cancer Product BrachySil(TM)
April 8th, 2005
pSivida Expands Market for Lead Cancer Product BrachySil(TM)
Abstract:
pSivida Limited today announced it has initiated a full development of its proprietary BrachySil(TM) product in a second key cancer indication. Development has commenced to evaluate the efficacy and safety of this novel brachytherapy product in pancreatic cancer, with the clinical program scheduled to commence before the end of 2005.
Source:
businesswire
Related News Press |
Possible Futures
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Nanomedicine
High-tech 'paint' could spare patients repeated surgeries March 8th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||